Top Markets
Coin of the day
Wellbiotec Co., Ltd. Wellbiotec Co., Ltd.

Wellbiotec Co., Ltd.

010600
Rangering i aksjer #39007
Established in Seoul, South Korea, in 1975, Wellbiotec Co., Ltd. operates a... Established in Seoul, South Korea, in 1975, Wellbiotec Co., Ltd. operates a multifaceted business both domestically and on the international stage. The company specializes in the manufacturing and distribution of various leather goods, catering to products such as footwear, handbags, automotive interiors, and steering wheel coverings. Beyond its leather operations, Wellbiotec provides extensive logistics solutions, which include consulting, container management, warehousing, customs clearance, and transportation agency services. Furthermore, the company is deeply involved in the healthcare sector, offering product research and development, expert consultation, distribution, and sales for general and specialized medicines, nutritional supplements, diagnostic kits, and cosmeceuticals. Additionally, Wellbiotec extends its reach into the entertainment industry through a casting agency, celebrity nurturing, content creation, and multi-channel network management. Rounding out its diverse activities, the firm also maintains a presence in the food and beverage market.
Aksjekurs
$0.00760643
Sist synkronisert: 2026-01-23
Markedsverdi
$691.60K
Endring (1 dag)
-25.74%
Endring (1 år)
-98.12%
Land
KR
Handel Wellbiotec Co., Ltd. (010600)
Inntekter for Wellbiotec Co., Ltd. (010600)
Inntekter i 2026 TTM: 0
Ifølge Wellbiotec Co., Ltd. sine nyeste økonomiske rapporter er selskapets nåværende resultat 0. I 2026 hadde selskapet et resultat på 0, lik resultatet i 2026, som var 0. Resultatet som vises på denne siden er resultat før renter og skatt, eller EBIT.
Inntektshistorikk for Wellbiotec Co., Ltd. fra 2026 til 2026
Inntekter ved slutten av hvert år
År Inntekter Endre
Ikke nok data for de angitte datoene.
Inntekter for lignende selskaper eller konkurrenter
Selskap Inntekter Forskjell i inntekter Land
- -
SE
$1.24B -
US
$1.73B -
CN
$1.07B -
IT
$637.65M -
PL